Navigation Links
Technology Predicts Outcome of Child Heart Surgery

Georgia Tech and Emory University researchers have developed an innovative new technology that will help pediatric cardiac surgeons design and test a customized// surgical procedure before they ever pick up a scalpel. With a better understanding of each child’s unique heart defect, surgeons could greatly improve the likelihood that children with complex defects requiring multiple surgeries over a period of several years could have smoother recoveries and an improved quality of life after their operations.

The technology, known as image-based surgical planning and developed with the help of pediatric cardiologists and pediatric surgeons at The Children’s Hospital of Philadelphia (CHOP) and Emory University, creates a three-dimensional model of the child’s heart with data from the child’s MRI scans at different times in the cardiac cycle, also called a 4D MRI. The models allow surgeons to visualize the direction of blood flow and determine any energy loss in the heart. So if a surgeon were planning a certain correction to an area of a child’s heart, a model created by the system would show the surgeon how well blood would flow through the newly configured heart.

The goal of the Georgia Tech/Emory project is to create a complete system that allows surgeons to get a detailed look at the child’s heart functions with the new MRI system, design surgical procedures for optimum post-operative performance and evaluate the heart’s performance with a sophisticated blood flow computer simulation.

The work was presented this month at the American Heart Association’s Scientific Sessions meeting in Chicago and has been published in Circulation and the Annals of Thoracic Surgery.

“We use the MRI images and time data to create models of these children’s vascular systems and hearts to simulate how they currently work and how they could work after surgery,” said Ajit Yoganathan, Ph.D., a co-principal investigator on the project and asso
'"/>




Page: 1 2 3

Related medicine news :

1. New Technology In MRI Scan Help Test Brain Cancer Therapy
2. Emergence Of New Gene Scanning Technology In Disease Research
3. Scientists Develop New Technology To Find About Human Ancestors’ Teet
4. Scientists Consider About New Technology Called Nanotechnology
5. Prostate Cancer Can Be Treated By Application Of LASER Technology
6. Georgia Institute of Technology develops doppler Vein finder
7. Novel Technology For Early Detection of Gastrointestinal Cancer
8. Winter Blues Treated by Breakthrough Lighting Technology
9. Bio-Technology Initiatives to Feed Research On Sorghum Crop
10. Technology Can Help Fight Health Care Costs
11. Technology at its nano best: hand-held lab-on-a-chip for blood tests
Post Your Comments:
(Date:11/20/2008)...ng is everything, and that certainly appears to be...ur months before the height of cold and flu season...a than children born at any other time of year, ac...he birth and medical records of more than 95,000 c...e whether date of birth in relationship to the pea...
(Date:11/20/2008)... NOVEMBER 2008 The consumption of illicit or nonc...worldwide and contributes significantly to the glo...eleased today by the International Center for Alco... of noncommercial alcohol, defined as traditional ... local trade and counterfeit or unregistered produ...
(Date:11/20/2008)...g could be key to new disease-fighting therapies ,... New research on mice suggests inhibiting a protei...ove to be key to cancer-fighting treatments. , ...rsite catholique de Louvain, in Belgium, found tha... on whether they are in regions rich in oxygen or ...
(Date:11/20/2008)...RNewswire-USNewswire/ -- The National Minority Qua...ical Association,s recent decision to develop a He...an and patient advocates to join the Forum in enco...e plans. , , "Physicians and lawyers -- eve.... Puckrein, PhD, President and Chief Executive Off...
Breaking Medicine News(10 mins):Health News:Fall babies: Born to wheeze? 2Health News:Report finds extensive use of illicit alcohol 2Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2
...ublished a research report on recommendations to i...lth-worker performance is a widespread problem for...t issue of The Lancet researchers had reviewed the...endations for how high-quality health-worker perfo...
... the day when it will be possible to correct the e...h normal ones. Gene therapy refers to the treatmen...es into abnormal cells. The hope is that the trans...t rather than merely alleviating its damage. Getti...
...the direction that a dose of stress everyday can s...evels of daily stress are linked to a decreased ri...udy carried out at the National Institute of Publi...f over 6,500 women were followed for 18 years and ...
...sclerosis (MS) may gain from treatment with Interf...ent with interferon appears to reduce the formatio... with multiple sclerosis (MS), including lesions t...called black holes, on magnetic resonance imaging ...
Other Medicine News:Health News:Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement 2Health News:Patients Of MS Are Not At Risk From The Interferon Treatment 2
(Date:11/20/2008)...ical data from a prospective,registry presented t...DVT,treatment with the Trellis(R) Peripheral Infu...ara, CA) successfully breaks up the blood clot in ...technique, called isolated pharmacomechanical thro...fely than current catheter-directed thrombolysis,...
(Date:11/20/2008)...swire/ -- The Scandinavian-based drug,development...studies on its,lead antimicrobial candidate LTX-1...dies showed that the novel lytic peptidomimetic ha...tly better towards killing Staphylococcus,aureus ...dard drugs. In,addition to this it has proven eff...
(Date:11/19/2008)...wire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and Mi...y of,Takeda Pharmaceutical Company Limited (TSE: ...se 3 MONET1 trial evaluating motesanib (AMG 706) i... the first-line treatment of,advanced non-small c...nded,following a planned safety data review of 60...
(Date:11/19/2008)...ngs on critical enzyme,s regulation may hold key t...sorders , , MEMPHIS, Tenn., Nov. 19 /PRNews...en,s Research Hospital have gained new insights in...es called calpains. , , As the cell,s mole...lular processes, including the movement of cells i...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3ValueOptions 28R 29 New Mexico Provides 2410 3 Million for Community Behavioral Health Care Organizations 17390 1ValueOptions 28R 29 New Mexico Provides 2410 3 Million for Community Behavioral Health Care Organizations 17390 2JIC Invests in Three New Alternative Energy Projects 4751 1JIC Invests in Three New Alternative Energy Projects 4751 2JIC Invests in Three New Alternative Energy Projects 4751 3JIC Invests in Three New Alternative Energy Projects 4751 4JIC Invests in Three New Alternative Energy Projects 4751 5American Cancer Society report details cancer prevention efforts 17385 1American Cancer Society report details cancer prevention efforts 17385 2American Cancer Society report details cancer prevention efforts 17385 3American Cancer Society report details cancer prevention efforts 17385 4Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 1Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 2Government Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security Surveillance 2989 3
...WIRE)--Apr 3, 2007 - Arrowhead Research,Corporatio...majority-owned subsidiary Calando Pharmaceuticals,...ive effect of the siRNA sequence,selected as the t...und, CALAA-01., The paper, entitled "Potent siRNA ...2 Reduce Cell Proliferation In vitro and In,vivo",...
...ewly published results in the,International Journa...servational ‘PREDICTIVE™ study’*...ople effectively treats diabetes,without causing w...amining patient outcomes when,Levemir® –...he everyday clinical setting. In the European coho...
Other Medicine Technology:Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3New Data Confirm That Use of Levemir Can Limit Weight Gain 2New Data Confirm That Use of Levemir Can Limit Weight Gain 3New Data Confirm That Use of Levemir Can Limit Weight Gain 4New Data Confirm That Use of Levemir Can Limit Weight Gain 5New Data Confirm That Use of Levemir Can Limit Weight Gain 6
... of the most modern lithotripters available today ...om being designed for the treatment of the entire ...LITH SLX can also be employed for a variety of oth...e for the treatment of gallstones or for orthopead...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only.
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: